In this context, we showed that exposure to cisplatin of cancer cells of gynecological origin induced the occurrence of m.13828C>T/MT-ND5 and the m.8156G>T/MT-CO2 mutations [56]. The gene discussed is MT-ND5; the disease is cancer.